Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioinformatics -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (73)	1/29/2007 12:57:46 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 80

This one is 3,938 Euros, which is about $5,100 USD Bioinformatics - Global Strategic Business Report Global Industry Analysts, Inc., Sep 2006, Pages: 577 researchandmarkets.com I'm not gonna list them, I see Eidogen-Sertanty which came up in a DDD or a Bioitworld article I was re-reading the other day. Sertanty bought Libraria in 2003, your trivia for the day. Tavistock Life Sciences owns Kalypsys and Sertanty (and several others) --bonus trivia for the day. They happen to have a collaboration drugdiscoverynews.com No point to this--trivia, trivium.